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For several decades the murine exper-
imental model of Leishmania infection
has been invaluable in deciphering events
occurring during the innate immune
response and those involved in the differ-
entiation of CD4+ T helper cells. Initially,
most studies inoculated mice subcuta-
neously into the hind footpad with a high
dose of stationary phase parasites (1 to
3 × 106). In recent years, new protocols
have been adopted to better mimic the nat-
ural transmission of the parasite caused by
the bite of infected sand flies. To this end,
low numbers of parasites (10–1000 meta-
cyclic promastigotes) are injected intra-
dermally in the ear. However, given the
different anatomy of the ear compared to
the footpad, monitoring lesion develop-
ment in the ear is technically more difficult
and until now there has been no consen-
sus on how to monitor lesion progression
in this anatomic region. The various meth-
ods, which are currently used, are listed
below:
1. Diameter: The first reported and
also most commonly used technique
to measure lesional expansion, is by
monitoring the induration diameter
(Mitchell, 1983; Belkaid et al., 1998,
2000).
2. Volume: Lesional volume can be mea-
sured in three dimensions and reported
as ellipsoids according to the following
equation [(a/2 × b/2 × c/2) × 4/3π]
(Maurer et al., 2006).
3. Thickness: Swelling across the trans-
verse plane of the pinna can be mea-
sured using a caliper. Considering the
narrowness of this dimension in a nor-
mal ear, thickness is technically diffi-
cult to quantify (Rosas et al., 2005; de
Moura et al., 2007).
4. Score: To our knowledge, only one
group has developed a scoring system,
which is based on lesion diameter. This
technique classifies 4 categories of dis-
ease severity ranging from small, local-
ized swellings (scored 1) to advanced
lesions larger than 6mm in diameter
(score 4) (Baldwin et al., 2007).
5. Surface: A more sophisticated
approach requires bioluminescent par-
asites, through which in vivo imaging is
able to delimit and quantify the area of
active infection (Lecoeur et al., 2007).
In order to better evaluate these mea-
surement systems, we compared them
across various murine models known
for their diverse disease outcome in
Leishmania major infection. To this end,
BALB/c, C57BL/6 and MyD88−/− mice
were inoculated intradermally in the
central ear pinna with infectious pro-
mastigotes of L. major LV39. The 10μl
inoculations were either given at a high
dose (105 stationary-phase parasites) or
a low dose (103 metacyclic promastig-
otes). For high dose inoculation, no sig-
nificant differences in lesion development
were observed between stationary-phase
or purified metacyclic promastigotes (data
not shown). The evolution of lesion devel-
opment was then analyzed through pre-
viously described methods and used to
develop a more robust scoring system as
presented below (Figure 1).
- Diameter: Among the techniques
previously described, measuring lesion
diameter proves to be most precise
and representative of what is observed
visually. However, major limitations
of this technique become apparent
at extremes in the infection time
course. For instance, early events like
inflammation and the appearance of a
non-measurable papule are overlooked
during the first weeks of infection, as
seen in high dose infected C57BL/6
mice and low dose infected BALB/c
mice (Figure 1A). Further, late events
like necrosis and tissue destruction are
not evaluated at all. Indeed, because
there is a plateau in lesion diameter
during late infection of susceptible
mice (BALB/c and MyD88−/−), this
method gives the impression that the
disease is stabilizing when, in fact,
the lesions are still progressing with
the appearance of necrotic skin damage
(Figure 1A).
- Volume: Lesion enlargement can also
be measured by determining the pro-
gression of its volume. This method is
better suited to monitoring large lesions
in susceptible mice such as BALB/c and
MyD88−/− mice, as lesion development
in Leishmania-resistant mouse strains,
such as C57BL/6 mice, is reduced to
a minor or nearly nonexistent phe-
notype (Figure 1B). Nevertheless,
limitations are still observed when
monitoring these larger lesions at
later time points, where ulcerations,
necrosis and atrophy degrade the
lesional volume making them appear
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FIGURE 1 | A new scoring system to monitor lesion development of
cutaneous leishmaniasis following Leishmania infection in the murine
ear dermis. C57BL/6, MyD88−/− and BALB/c mice were inoculated
intradermally in the central ear pinna with 10μl of 105 stationary phase
Leishmania major promastigotes (high dose) or 103 metacyclic promastigotes
(low dose). Throughout the infection, lesion size was monitored and the
results were expressed using the different methods: (A) Diameter; (B)
Volume; (C) Thickness and (D) with our newly proposed scoring system.
Below, a table describing this scoring method is given (E). Pictures of BALB/c
infected ears representing selected lesion scores of lesion throughout the
infection are presented. Data are representative of at least two independent
experiments with five mice per group (females, 5–8 weeks old). Results
shown are mean + s.e.m. Statistical comparison to C57BL/6 were performed
using the Student’s t-test ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
to become smaller in BALB/c and to a
lesser extent also in MyD88−/− mice
(Figure 1B).
- Thickness: We found the measurement
of lesional thickness to be the least
precise technique to follow cutaneous
leishmaniasis in murine ear infection
(Figure 1C). Moreover, the technical
difficulty of this method resulted in a
wide variability between different stud-
ies as well as between investigators. In
addition, differences between suscep-
tible and resistant mice are reduced
(Figure 1C), making analysis of slight
modulation between groups more diffi-
cult. Most importantly, the appearance
of necrosis and tissue loss is also not
considered.
In conclusion, we found that all of
the previously described techniques for
monitoring auricular cutaneous leishma-
niasis in a murine model, did not accu-
rately measure lesion development over
the full course of disease or failed to repre-
sent what is observed visually. Limitations
were particularly evident at extremes of
the infection time course, where events
such as the first signs of inflammation
and end-stage necrosis are not considered.
For this reason, we propose to introduce a
new scoring system. This system will take
into account each step of lesion evolution
occurring during the infection: from the
first signs of lesional inflammation such
as erythema to the development of necro-
sis with tissue loss (Figure 1E). Further, we
propose it as suitable for both low and high
dose infections.
Briefly, lesion scores range between
0 and 8 (Figure 1E). At the onset of
infection, the first visible sign of infec-
tion is erythema (redness due to capillary
swelling) and is assigned a score of 0.5.
The appearance of palpable swelling or a
papule receives a score of 1. As soon as bor-
ders are discernable, lesional size is quan-
tified by measurement of the length and
breadth using a caliper. The longer dimen-
sion (length) is used to assign a score
for each increment of 0.5mm. For exam-
ple, a length between 2.00 and 2.49mm
is awarded a score of 2, while the next
interval (2.50–2.99mm) is given a score of
2.5, and so on until a maximum value of
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5.50mm (score 5.5). For lesions that have
a diameter higher than 5.50mmbut do not
show any signs of necrosis, a score of 5.5 is
attributed. The first evidence of necrosis is
gauged by an increase of 0.5 points (score
6). Severe necrotic lesions without tissue
loss receive a score of 7 and once tissue
destruction at the site of infection appears,
a score of 8 is attributed (Figure 1E).
When a score of 7–8 is reached, mice are
sacrificed for ethical reasons.
Consequently, this scoring system
depicts the evolution of lesion develop-
ment in a precise manner that accurately
represents the phenotypic progression of
disease (Figure 1D). Importantly, small
modulations in lesion onset and evolu-
tion are also discernable, especially at the
beginning of lesion formation and at later
time points when tissue modifications
and necrosis occur. Besides being a useful
method of quantifying disease, a repre-
sentative picture would be informative,
especially at the onset of necrosis.
Thismethod can be used independently
of the number of parasites inoculated and
we also propose it for monitoring “natu-
ral” infection models, where small num-
bers of parasites are transmitted by an
infected sand fly. While this study clearly
shows the limitations of using single mea-
surements in quantifying disease progres-
sion for high-dose infections, it also shows
that low-dose infections may be accurately
monitored by lesional diameter, as this
parameter closely mirrored that of the
score. An advantage of our system how-
ever, is the possibility to present lesion
evolution from mice resistant or suscep-
tible to Leishmania infection on the same
graph, without the bias created by the
under-representation of very small and
very large lesions that was observed in the
other techniques. Finally, since the pre-
sented method is technically easy to apply
it will allow comparison and standard-
ization between the increasing number
of studies performed using intradermal
inoculation of Leishmania in both basic
and translational research. This should
help evaluating novel vaccine candidates as
well as drug screening in murine exper-
imental Leishmania infection models in
the ear.
ACKNOWLEDGMENTS
We thank Prof. Pascal Launois for help-
ful discussions and all the members
of CIIL animal facility for their gen-
eral support. This study was carried out
in strict accordance with the recom-
mendations in the Guide for the care
and use of laboratory animals from the
Department of Security and Environment
(DSE) in the state of Vaud, Switzerland
(license number 1810 and 2113). This
work was funded by the Swiss National
Foundation and the Pierre Mercier
Foundation.
REFERENCES
Baldwin, T., Sakthianandeswaren, A., Curtis, J. M.,
Kumar, B., Smyth, G. K., Foote, S. J., et al. (2007).
Wound healing response is a major contributor
to the severity of cutaneous leishmaniasis in
the ear model of infection. Parasite Immunol.
29, 501–513. doi: 10.1111/j.1365-3024.2007.
00969.x
Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J.,
Noben-Trauth, N., Rowton, E., et al. (1998).
Development of a natural model of cutaneous
leishmaniasis: powerful effects of vector saliva
and saliva preexposure on the long-term out-
come of Leishmania major infection in the mouse
ear dermis. J. Exp. Med. 188, 1941–1953. doi:
10.1084/jem.188.10.1941
Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon,
G., and Sacks, D. (2000). A natural model of
Leishmania major infection reveals a prolonged
“silent” phase of parasite amplification in the skin
before the onset of lesion formation and immu-
nity. J. Immunol. 165, 969–977. doi: 10.4049/jim-
munol.165.2.969
de Moura, T. R., Oliveira, F., Novais, F. O.,
Miranda, J. C., Clarencio, J., Follador, I., et al.
(2007). Enhanced Leishmania braziliensis infec-
tion following pre-exposure to sandfly saliva. Plos
Negl. Trop. Dis. 1:e84. doi: 10.1371/journal.pntd.
0000084
Lecoeur, H., Buffet, P., Morizot, G., Goyard, S.,
Guigon, G., Milon, G., et al. (2007). Optimization
of topical therapy for leishmania major local-
ized cutaneous leishmaniasis using a reliable
C57BL/6 Model. Plos Negl. Trop. Dis. 1:e34. doi:
10.1371/journal.pntd.0000034
Maurer, M., Lopez Kostka, S., Siebenhaar, F., Moelle,
K., Metz, M., Knop, J., et al. (2006). Skin
mast cells control T cell-dependent host defense
in Leishmania major infections. FASEB J. 20,
2460–2467.doi: 10.1096/fj.06-5860com
Mitchell, G. F. (1983). Murine cutaneous
leishmaniasis - resistance in reconstituted
nude-mice and several f1-hybrids infected with
leishmania-tropica-Major. J. Immunogenet.
10, 395–412. doi: 10.1111/j.1744-313X.1983.
tb00351.x
Rosas, L., Keiser, T., Barbi, J., Septer, A., Kaczmarek, J.,
and Satoskar, A. R. (2005). Genetic differences in
host susceptibility of mice to Leishmania mexicana
revealed in a low dose ear infection model. Am.
J. Trop. Med. Hyg. 73, 365–366. doi: 10.1093/
intimm/dxh313
Conflict of Interest Statement: The authors declare
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 10 January 2014; accepted: 06 May 2014;
published online: 28 May 2014.
Citation: Schuster S, Hartley M-A, Tacchini-Cottier F
and Ronet C (2014) A scoring method to standard-
ize lesion monitoring following intra-dermal infection
of Leishmania parasites in the murine ear. Front. Cell.
Infect. Microbiol. 4:67. doi: 10.3389/fcimb.2014.00067
This article was submitted to the journal Frontiers in
Cellular and Infection Microbiology.
Copyright © 2014 Schuster, Hartley, Tacchini-Cottier
and Ronet. This is an open-access article distributed
under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduc-
tion in other forums is permitted, provided the original
author(s) or licensor are credited and that the origi-
nal publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with
these terms.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org May 2014 | Volume 4 | Article 67 | 3
